DDReg pharma

Quailty Driven by Passion

Submit Query

Author name: development

Roadmap to Drug Approval in China Market

Breaking Into China’s Pharma Market? Here’s Your Roadmap to Drug Approval Success

All Category, Blogs /

Due to the increasing demand for high-quality healthcare, China has emerged as a major market for pharmaceutical products and is now one of the world’s leading manufacturers of pharmaceuticals. The market is ambitious and places emphasis on innovation and domestic research and development. By 2024, the Chinese pharmaceutical market exceeded USD 80 billion in revenue, […]

Breaking Into China’s Pharma Market? Here’s Your Roadmap to Drug Approval Success Read More »

Cybersecurity in Connected Medical Devices in Modern Health

Cybersecurity in Connected Medical Devices: Compliance and Risk Mitigation

All Category, Blogs, Medical Device, regulatory /

The integration of connected medical devices into healthcare systems has revolutionized patient care, enabling real-time monitoring and data-driven decision-making. However, this interconnectedness also introduces significant cybersecurity risks that can compromise patient safety, data privacy, and the integrity of healthcare operations. As cyber threats evolve, it is imperative for manufacturers, healthcare providers, and regulators to adopt

Cybersecurity in Connected Medical Devices: Compliance and Risk Mitigation Read More »

Complete guide of pharmacovigilance standard operating procedure

Basic Guide to Writing Effective Pharmacovigilance Standard Operating Procedures (SOPs)

All Category, Blogs, Pharmacovigilance /

Pharmacovigilance Standard Operating Procedures (SOPs) are the foundation of every reliable PV system. Well-written SOPs are the backbone of your pharmacovigilance (PV) system: they encode legal obligations into daily practice, reduce variability, protect data integrity, and demonstrate control during inspections. They transform global regulatory requirements into clear, actionable workflows that ensure patient safety, regulatory compliance, and

Basic Guide to Writing Effective Pharmacovigilance Standard Operating Procedures (SOPs) Read More »

Point-of-Care Diagnostics in Healthcare

Point of Care Diagnostics Making Healthcare More Accessible 

All Category, Blogs, Clinical Regulatory, Medical Device, regulatory /

Point-of-care diagnostics (POC) represent one of the fastest-growing segments in the global in-vitro diagnostics (IVD) industry, enabling rapid medical testing at or near the site of patient care. This capability significantly reduces diagnostic turnaround times, facilitates immediate clinical decision-making, and improves patient outcomes, especially in resource-limited or time-critical scenarios. The convergence of advanced biosensor technologies,

Point of Care Diagnostics Making Healthcare More Accessible  Read More »

All about CAR T-cell therapy in curing cancer

CAR-T Cell Therapy: A Cancer Cure with Proven Remission Success 

All Category, Blogs /

Just a decade ago, the idea of “reprogramming” a patient’s own immune cells to wipe out cancer sounded like something from a sci-fi movie. Today, it’s an approved, life-saving treatment for thousands of people and it’s changing the way we think about curing cancer.Cancer begins when cells in the body start multiplying uncontrollably and spread

CAR-T Cell Therapy: A Cancer Cure with Proven Remission Success  Read More »

Digital therapeutics (DTx) for Empowering Patients

Digital Therapeutics: Empowering Patients to Take Charge of Chronic Conditions 

All Category, Blogs, regulatory /

Chronic conditions such as diabetes, hypertension, COPD, and depression account for over 70% of global healthcare costs and are the leading cause of disability-adjusted life years (DALYs) worldwide (WHO, 2024). Traditional care pathways, while effective, often rely on episodic clinician interactions, leaving gaps in ongoing patient engagement, self-management, and behavior modification.    Digital Therapeutics (DTx)

Digital Therapeutics: Empowering Patients to Take Charge of Chronic Conditions  Read More »

How Pharmacogenomics Is Powering Personalized Medicine

Your Genes, Your Treatment Plan: How Pharmacogenomics Is Powering Personalized Medicine

All Category, Blogs, Clinical Regulatory, regulatory /

A patient walks into a clinic. Two people have the same diagnosis, yet their treatments are completely different. One responds quickly. The other experiences side effects. The difference? Their genes.    Welcome to the world of pharmacogenomics, where your genetic blueprint guides your treatment plan. This isn’t a glimpse of future medicine, it’s already reshaping

Your Genes, Your Treatment Plan: How Pharmacogenomics Is Powering Personalized Medicine Read More »

Regulatory expertise for medical device approval in India

Achieve Faster Medical Device Approval in India with Regulatory Expertise

All Category, Blogs, regulatory /

India’s medical device market is one of the fastest growing in the world, According to Invest India, India’s medical device market valued at around USD 11 billion in 2022–23, is projected to reach USD 50 billion by 2030, growing at a CAGR of approximately 16.4% [Report]. As global manufacturers and startups set their sights on this high-potential market, regulatory

Achieve Faster Medical Device Approval in India with Regulatory Expertise Read More »

DDReg Honored at ET Health Conclave 2025

DDReg Honored at ET Health Conclave 2025 for Excellence in Life Sciences Services

All Category, News and Events /

Gurgaon, July 27, 2025 — DDReg Pharma, a trusted global partner in life science industry offering a wide array of services including regulatory consulting and pharmacovigilance solutions, was recognized with two prestigious awards at the ET Health Conclave 2025, held at the Grand Hyatt, Gurgaon:    Excellency in Pharmaceutical Consulting & Compliance  Top Emerging Company

DDReg Honored at ET Health Conclave 2025 for Excellence in Life Sciences Services Read More »